Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Optimal Diagnosis and Treatment Strategy of Major Depressive Disorder Based on Anhedonia

NCT05389046 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT05389046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05389046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Optimal Diagnosis and Treatment Strategy of Major Depressive Disorder Based on Anhedonia
Lead sponsor
Peking University
Phase
Not applicable
Overall status
Unknown status
Start date
August 15, 2022
Completion date
December 31, 2025
Enrollment
252 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

outpatients / inpatients with depression